The research-based pharmaceutical companies have a large amount of valuable data from studies, field reports, advisory boards and side effect reports.
Provided that this data complies with the national provisions of drug legislation and industry codes, it may be uploaded to Digital Doctor House on specially designated drug information pages.
Drug data is only seen by doctors and pharmacists who are registered in the same country from which the data originates. Doctors and pharmacists have no access to data originating from countries other than those registered themselves.
This prevents “off-label” information from the industry.